Results 11 to 20 of about 68,927 (203)

Incremental haemodialysis [PDF]

open access: yesNephrology Dialysis Transplantation, 2015
Thrice-weekly haemodialysis schedules have become the standard default haemodialysis prescription worldwide. Whereas the measurement of residual renal function is accepted practice for peritoneal dialysis patients and the importance of residual renal function in determining technique success is well established, few centres routinely assess residual ...
Jonathan, Wong   +3 more
openaire   +2 more sources

The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort. [PDF]

open access: yes, 2015
Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmission in the UK, all haemodialysis patients are regularly screened, and if susceptible to Hepatitis B virus (HBV) infection ...
Cross, J   +6 more
core   +1 more source

Home haemodialysis : trends in technology [PDF]

open access: yes, 2011
Self management and home-based dialysis therapies offer the prospect of improved patient experience and outcomes. To allow more patients to realize these benefits requires changes in technology which focus on maximizing the ease and minimizing the ...
Farrington, Ken, Greenwood, Roger
core   +2 more sources

Establishing an evidenced-based dietetic model of care in haemodialysis using implementation science [PDF]

open access: yes, 2019
To establish an evidence-based dietetics service in an in-centre haemodialysis unit utilising implementation science.The service was developed through the Knowledge-to-Action Framework.
Campbell, Katrina L   +3 more
core   +1 more source

Evaluation of a Phosphate Management Protocol to Achieve Optimum Serum Phosphate Levels in Hemodialysis Patients [PDF]

open access: yes, 2008
Original article can be found at: http://www.sciencedirect.com/science/journal/10512276 Copyright National Kidney Foundation, Inc. DOI: 10.1053/j.jrn.2008.05.003To evaluate the effectiveness of a protocol designed to optimize serum phosphate levels in ...
Cheung, C.F.   +5 more
core   +1 more source

Immediate access arteriovenous grafts versus tunnelled central venous catheters: study protocol for a randomised controlled trial [PDF]

open access: yes, 2015
Background Autologous arteriovenous fistulae (AVF) are the optimal form of vascular access for haemodialysis. AVFs typically require 6 to 8 weeks to “mature” from the time of surgery before they can be cannulated.
Aitken, Emma   +6 more
core   +2 more sources

Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients [PDF]

open access: yes, 2018
COSMOS is sponsored by the Bone and Mineral Research Unit (Hospital Universitario Central de Asturias), SAFIM (Sociedad Asturiana Fomento Investigaciones Óseas), the European Renal Association-European Dialysis and Transplant Association, the National ...
Cabezas Rodríguez, I.   +3 more
core   +2 more sources

Thrice weekly nocturnal in-centre haemodiafiltration: a 2-year experience [PDF]

open access: yes, 2015
Background: Adequate control of plasma phosphate without phosphate binders is difficult to achieve on a thrice-weekly haemodialysis schedule. The use of quotidian nocturnal dialysis is effective but not practical in the in-centre setting.
Dey, V., Hair, M., Spalding, E. M.
core   +1 more source

The effect of polyphenol-rich Interventions on cardiovascular risk factors in haemodialysis: A systematic review and meta-analysis [PDF]

open access: yes, 2017
End-stage kidney disease is a strong risk factor for cardiovascular-specific mortality. Polyphenol-rich interventions may attenuate cardiovascular disease risk factors; however, this has not been systematically evaluated in the hemodialysis population ...
Campbell, Katrina   +5 more
core   +4 more sources

Identifying critically important vascular access outcomes for trials in haemodialysis : an international survey with patients, caregivers and health professionals [PDF]

open access: yes, 2020
BACKGROUND: Vascular access outcomes reported across haemodialysis (HD) trials are numerous, heterogeneous and not always relevant to patients and clinicians. This study aimed to identify critically important vascular access outcomes.
Craig, JC   +24 more
core   +1 more source

Home - About - Disclaimer - Privacy